Qube Research & Technologies LTD Nex Immune, Inc. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.2 - $0.3 $0 - $1	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $1,078 - $31,447	-1,797 Reduced 11.34%	14,049 $8,000
Q2 2022 Aug 15, 2022	BUY	$1.61 - $4.68 $25,512 - $74,159	15,846 New	15,846 $26,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.